By Rohit Malpani, Brook Baker & Mohga Kamal-Yanni
Two competing approaches to promote access to medicines were born during the HIV/AIDS pandemic in the year 2000. Today, at the height of the COVID-19 pandemic, these same approaches are once more on a collision course.
https://healthpolicy-watch.news/gates-foundation-address-systemic-covid-19/
Mister Chairman and Members of the Commission, thank you for the opportunity to testify today on the Commission’s investigation on extending the WTO June decision to diagnostics and therapeutics on be
By mid 1990, new medicines to treat HIV became a reality and people living with the virus in the North had their lives turned around. However, people in the South, where most of the infection was, wer
I participated in a debate at The British medical Journal (bmj) on access to medical technologies at the time of pandemic. I argued that governments should take control and that left to pharmaceutical